Trial Profile
An Open Study to Evaluate the Efficacy, Safety and Sustained Effect of Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With Chronic Hepatitis B Associated Hepatocellular Carcinoma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2014
Price :
$35
*
At a glance
- Drugs Clevudine (Primary) ; Adefovir
- Indications Hepatitis B; Liver cancer
- Focus Therapeutic Use
- Sponsors Bukwang Pharmaceutical
- 17 Dec 2014 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Dec 2010 New trial record